Complete AI Training
Sign inGet my AI kit

Your job's AI kit

Get your AI kit

Tell us who you are and what you do. We show you your kit right away and email you the link: skills, prompts, AI agents, MCP servers and courses for your job.

500+ jobs ready, and we make a kit for any other job. No payment needed to look.

Share

AI news ·

SCIEX updates ZenoTOF platform with ZT Scan DIA 3.0 and Echo MS+ integration

SCIEX upgraded its ZenoTOF line, yielding 10 to 40 percent gains in low-input proteomics. The updates target a mass spectrometry market projected at $10.7 billion by 2031.

3 min read
Management

At the ASMS 2026 conference, SCIEX introduced platform-wide upgrades to its ZenoTOF line to accelerate high-throughput translational research. These updates address the pharmaceutical industry's need for faster, more sensitive analytical technologies as the global mass spectrometry market projects toward $10.7 billion by 2031.

Hardware and throughput upgrades

SCIEX introduced ZT Scan DIA 3.0, an iteration of data-independent acquisition (DIA) technology. Traditional data-dependent acquisition isolates precursor ions randomly, often causing missing values in large sample sets. DIA fragments all detectable peptides, ensuring consistent data capture.

When paired with the ZenoTOF 8600 enhanced sensitivity mode, this setup yields 10 to 40 percent performance gains in low-input nanoflow proteomics. This baseline sensitivity is necessary for single-cell proteomics, where biological material is scarce.

To break throughput barriers, SCIEX integrated the Echo MS+ system with the ZenoTOF 8600 platform. The Echo MS+ uses acoustic ejection mass spectrometry to shoot nanoliter droplets directly into an open port interface. This contactless method removes traditional injection needles, eliminates lengthy separation gradients, and reduces mechanical carryover risks, allowing sampling rates of up to one sample per second.

AI and software automation

Integrating artificial intelligence into daily lab operations is shifting from an experimental concept to a standard practice. The new SCIEX OS 5.0 software includes AI-enabled tools to automate peak picking and predict compound fragmentation patterns.

SCIEX OS 5.0 features a natural language "helpme" function to answer user questions and AI-enabled Calculated Columns for custom math without programming. These interface updates help offset the steep learning curves associated with high-end analytical instruments. For lab directors overseeing these transitions, understanding how to train staff on these tools is critical, making resources like the AI Learning Path for Biochemists relevant for upskilling technical teams.

The software also supports 21 CFR Part 11 requirements through role-based access controls and electronic audit trails. A Central Metrics Tracker monitors instrument status across the entire fleet to identify performance degradation before system failure occurs.

Structural characterization and data interoperability

SCIEX partnered with Trajan Scientific and Medical to bring automated hydrogen-deuterium exchange mass spectrometry (HDX-MS) to the ZenoTOF line. Manual execution of these assays often suffers from poor reproducibility due to environmental sensitivity. The automated platform pairs with Electron Activated Dissociation (EAD) to deliver zero-scrambling, amino-acid residue-resolved structural insights.

The company also announced bioinformatics collaborations with PEAKS, MS-Dial, and mzmine. These partnerships allow researchers to validate biomarkers without fragmenting data across proprietary software ecosystems.

Additionally, SCIEX released source modifications for compatibility with low-flow chromatography systems from Evosep and IonOpticks. An expanded agreement with IonOpticks will broaden access to analytical consumables, including Aurora XS columns.

Why this matters for lab managers

Laboratory directors must evaluate how new instrumentation fits their operational goals. Adopting these connected platforms reduces sample turnaround times and accelerates drug discovery data analysis.

However, this shift requires strong laboratory IT infrastructure to handle the massive digital outputs from continuous, high-throughput DIA workflows. Evaluating these advanced instruments with real-world, in-house samples remains the definitive method to ensure the technology meets a lab's exact sensitivity thresholds.

Jose Castro-Perez, Vice President of Product Management at SCIEX, summarized the company's direction: "Ultimately, we are not just delivering incremental performance - but a step change in how researchers can move across the omics continuum. This is just the beginning. Our commitment is simple - continuous innovation in this dynamic platform delivers for customers, across workflows."

References:

  • Heymann, T., et al. (2026). Scanning DIA on the ZenoTOF 8600 system enables ultra-sensitive and quantitative proteomics from single cells to post-translational modifications in a compact platform. bioRxiv, https://doi.org/10.64898/2026.03.12.711261
  • Li, J., Smith, L. S., & Zhu, H. J. (2021). Data-independent acquisition (DIA): An emerging proteomics technology for analysis of drug-metabolizing enzymes and transporters. Drug Discovery Today: Technologies, 39, 49-56. https://doi.org/10.1016/j.ddtec.2021.06.006
Share